References
- Gozlan H., El Mestikawy S., Pichat L., Glowinski J., Hamon M. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature 1983; 7: 140–142
- Marcinkiewicz M., Verge D., Gozlan H., Pichat L., Hamon M. Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain. Brain. Research 1984; 291: 159–163
- Hoyer D., Pazos A., Probst A., Palacios J. M. Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain. Research 1986; 376: 85–96
- Sprouse J. S., Aghajanian G. K. Electrophysiological responses of serotonergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse. 1987; 1: 309
- Pranzatelli M. R., Snodgrass S. R. The pharmacology of myoclonus. Clin. Neuropharmacol. 1986; 8: 99–130
- Blier P., DeMontigny C. Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: single-cell recording studies. J. Clin. Psychopharmacol. 1990; 10: 13S–20S
- Tricklebank M. D., Forler C., Fozard J. R. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioral response to 8-hydroxy-2-(di-N-propylamine)tetralin in the rat. Eur. J. Pharmacol. 1985; 106: 271–282
- Goodwin G. M., Green A. R. A behavioral and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors, Br. J. Pharmacol. 1985; 84: 743–753
- Pranzatelli M. R., Pluchino R. S. The relation of central 5-HT1A and 5-HT2 receptors: low dose agonist-induced selective tolerance in the rat, Pharmacol. Biochem. Behav. 1991; 39: 407–413
- Jacobs B. L. An animal model for studying central serotonergic synapses. Life. Sci. 1976; 19: 777–786
- Sloviter R. S., Drust E. G., Connor J. D. Specificity of a rat behavioral model for serotonin receptor activation. J. Pharmacol. Exp. Ther. 1987; 206: 339–347
- Jacobs B. L., Klemfuss H. Brainstem and spinal cord mediation of a serotonergic behavioral syndrome. Brain. Res. 1975; 100: 450–457
- Wieland S., Goodale D., Lucki I. Behavioral effects of 8-OH-DPAT: studies using the microtaxic ventricular injector. J. Neurosci. Meth. 1989; 30: 151–159
- Glennon R. Central serotonin receptors as targets for drug research. J. Med. Chem. 1987; 30: 1–12
- Pluchino R. P., Pranzatelli M. R. Comparative acute and chronic effects of putative 5-HT2 and 5-HT1A agonists in the rat: Is there more than one “serotonin syndrome?”. Soc. Neurosci. Abstr. 1988; 14: 306
- Hall M. D., Mestikawy S. El., Emerit M. B., Pichat L., Hamon M., Gozlan H. [3H]8-Hydroxy-2(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J. Neurochem. 1985; 44: 1685–1696
- SAS Institute, Inc. SAS User's Guide: Statistics. SAS Institute, Inc., Cary, NC 1985
- Goodwin G. M., DeSouza R. J., Green A. R. The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-N-propylamino)-tetralin(8-OH-DPAT): a model of presynaptic 5-HT1 function. Neuropharmacology 1985; 24: 1187–1194
- Hutson P. H., Donohoe T. P., Curzon G. Hypothermia induced by the putative 5-HT1A agonists LY165163 and 8-OH-DPAT is not prevented by 5-HT depletion. Eur. J. Pharmacol. 1987; 143: 221–228
- Goodwin G. M., DeSouza R. J., Wood A. J., Green A. R. The enhancement by lithium of the 5-HT1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism. Psychopharmacology 1986; 90: 488–493
- Larsson L.-G., Renyi L., Ross S. B., Svensson B., Angeby-Moller K. Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT. Neuropharmacology 1990; 29: 85–91
- de Souza R. J., Goodwin G. M., Green A. R., Heal D. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists. J. Pharmac. 1986; 89: 377–384
- Kennett G. A., Marcou M., Dourish C. T., Curzon G. Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur. J. Pharmacol. 1987; 138: 53–60
- Wellner S. A., DeMontigny C., Desrouches J., Desjardins P., Suranyi-Cadotte B. E. Autoradiographic quantification of serotonin1A receptors in rat brain following andidepressant drug treatment. Synapse. 1989; 4: 347–352
- Varrault A., Leviel V., Bockaret J. 5-HT1A-sensitive adenylyl cyclase of rodent hippocampal neurons: Effects of antidepressant treatments and chronic stimulation with agonists. J. Pharmacol. Exp. Therap. 1991; 257: 433–438
- Pranzatelli M. R. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist. Biochem. Pharmacol. 1991; 42: 1099–1105
- Eison A. S., Yocca F. D. Reduction in cortical 5-HT2 receptor sensitivity after continuous gepirone treatment. Eur. J. Pharmacol. 1985; 111: 389–392
- Yocca F. D., Wright R. N., Margraf R. R., Eison A. S. 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats. Pharmacol. Biochem. Behav. 1990; 35: 251–254